Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Sodium Nitrite in OHCA
NCT02987088Phase 1Completed
- Sponsor
- University of Washington
- Start
- Dec 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of sodium nitrite in cardiac arrest (SCA) (2 arms), sponsored by University of Washington. Primary endpoint: Plasma level of sodium nitrite at hospital arrival. Started Dec 2016; status: completed.
02
Drugs
sodium nitrite
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT02987088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02987088.